Advanced search
Publication Cover
Expert Opinion on Drug Safety Volume 13, 2014 - Issue 10
Submit an article Journal homepage
347
Views
10
CrossRef citations to date
0
Altmetric
Original Research

Late pulmonary complications of treating Hodgkin lymphoma: bleomycin-induced toxicity

Ádám JónaUniversity of Debrecen, Clinical Center, Division of Hematology, Institute for Internal Medicine and Department of Pulmonology, Nagyerdei krt. 98, H-4032 Debrecen, Hungary+36 52 411 717/56619; [email protected]
,
Zsófia MiltényiUniversity of Debrecen, Clinical Center, Division of Hematology, Institute for Internal Medicine and Department of Pulmonology, Nagyerdei krt. 98, H-4032 Debrecen, Hungary+36 52 411 717/56619; [email protected]
,
Zsófia UjjUniversity of Debrecen, Clinical Center, Division of Hematology, Institute for Internal Medicine and Department of Pulmonology, Nagyerdei krt. 98, H-4032 Debrecen, Hungary+36 52 411 717/56619; [email protected]
,
Ildikó GaraiScanomed Ltd, Budapest, Hungary
,
Mária SzilasiUniversity of Debrecen, Clinical Center, Division of Hematology, Institute for Internal Medicine and Department of Pulmonology, Nagyerdei krt. 98, H-4032 Debrecen, Hungary+36 52 411 717/56619; [email protected]
&
Árpád IllésUniversity of Debrecen, Clinical Center, Division of Hematology, Institute for Internal Medicine and Department of Pulmonology, Nagyerdei krt. 98, H-4032 Debrecen, Hungary+36 52 411 717/56619; [email protected]
Pages 1291-1297 | Published online: 18 Aug 2014

Citations (10)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Kekoa Taparra, Heshan Liu, Mei-Yin Polley, Kay Ristow, Thomas M. Habermann & Stephen M. Ansell. (2020) Bleomycin use in the treatment of Hodgkin lymphoma (HL): toxicity and outcomes in the modern era. Leukemia & Lymphoma 61:2, pages 298-308.
Read now
Maja D. Andersen, Peter Kamper, Alexander d’Amore, Michael Clausen, Hans Bentzen & Francesco d'Amore. (2019) The incidence of bleomycin induced lung toxicity is increased in Hodgkin lymphoma patients over 45 years exposed to granulocyte-colony stimulating growth factor. Leukemia & Lymphoma 60:4, pages 927-933.
Read now

Articles from other publishers (8)

Qing Wen, Jingjing Ge, Yaxin Lei, Yue Zhang, Xiaoshuang Kong, Wenhua Wang, Huting Hou, Zeyuan Wang, Siyu Qian, Mengjie Ding, Meng Dong, Linan Zhu, Mingzhi Zhang, Xudong Zhang & Qingjiang Chen. (2022) Real-world evidence of ABVD-like regimens compared with ABVD in classical Hodgkin lymphoma: a 10-year study from China. Journal of Cancer Research and Clinical Oncology 149:7, pages 3989-4003.
Crossref
Hira Shaikh, Zulfa Omer, Roman A. Jandarov, Morgan P. McBee, Jennifer Scheler, Bruce Mahoney & Tahir Latif. (2023) FDG PET/CT as a Tool for Early Detection of Bleomycin-Induced Pulmonary Toxicity. Lymphatics 1:1, pages 45-54.
Crossref
Ingemar Lagerlöf, Helena Fohlin, Gunilla Enblad, Bengt Glimelius, Christina Goldkuhl, Marzia Palma, Lisa Åkesson, Ingrid Glimelius & Daniel Molin. (2022) Limited, But Not Eliminated, Excess Long-Term Morbidity in Stage I-IIA Hodgkin Lymphoma Treated With Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine and Limited-Field Radiotherapy. Journal of Clinical Oncology 40:13, pages 1487-1496.
Crossref
Tara Cochrane, Belinda A. Campbell, Shane A. Gangatharan, Maya Latimer, Richard Khor, David R. H. Christie, Michael Gilbertson, Sumita Ratnasingam, Emma Palfreyman, Hui‐Peng Lee, Judith Trotman, Mark Hertzberg & Michael Dickinson. (2021) Assessment and management of newly diagnosed classical Hodgkin lymphoma: a consensus practice statement from the Australasian Lymphoma Alliance. Internal Medicine Journal 51:12, pages 2119-2128.
Crossref
Pradnya D. Patil & Tanmay S. Panchabhai. 2020. Handbook of Cancer Treatment-Related Symptons and Toxicities. Handbook of Cancer Treatment-Related Symptons and Toxicities 61 72 .
Moussab Damlaj, Mohsen Al-Zahrani, Ghulam Syed, Giamal Gmati, Bader Alahmari, Tabrez Pasha, Ayman Alhejazi & Ahmed Alaskar. (2019) Interim Functional Imaging Is an Independent Predictor of Progression-free Survival in Advanced Classical Hodgkin Lymphoma – A Real-world Analysis. Clinical Lymphoma Myeloma and Leukemia 19:1, pages e71-e79.
Crossref
Robert A. Watson, Hugo De La Peña, Maria T. Tsakok, Johnson Joseph, Sara Stoneham, Jonathan Shamash, Johnathan Joffe, Danish Mazhar, Zoe Traill, Ling-Pei Ho, Sue Brand & Andrew S. Protheroe. (2018) Development of a best-practice clinical guideline for the use of bleomycin in the treatment of germ cell tumours in the UK. British Journal of Cancer 119:9, pages 1044-1051.
Crossref
Ádám Jóna, Zsófia Miltényi, Szilárd Póliska, Bálint László Bálint & Árpád Illés. (2016) Effect of Bleomycin Hydrolase Gene Polymorphism on Late Pulmonary Complications of Treatment for Hodgkin Lymphoma. PLOS ONE 11:6, pages e0157651.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.